| Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... Medrxiv, 2021.01. 07.21249390, 2021 | 1311 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1018 | 2021 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 815 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 600 | 2021 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future MJ Schultz, MW Dünser, AM Dondorp, NKJ Adhikari, S Iyer, A Kwizera, ... Sepsis management in resource-limited settings, 1-24, 2019 | 239 | 2019 |
| Association of the quick sequential (sepsis-related) organ failure assessment (qSOFA) score with excess hospital mortality in adults with suspected infection in low-and middle … KE Rudd, CW Seymour, AR Aluisio, ME Augustin, DS Bagenda, A Beane, ... Jama 319 (21), 2202-2211, 2018 | 197 | 2018 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 189 | 2021 |
| Critical care bed capacity in Asian countries and regions J Phua, MO Faruq, AP Kulkarni, IS Redjeki, K Detleuxay, N Mendsaikhan, ... Critical care medicine 48 (5), 654-662, 2020 | 184 | 2020 |
| Recommendations for sepsis management in resource-limited settings MW Dünser, E Festic, A Dondorp, N Kissoon, T Ganbat, A Kwizera, ... Intensive care medicine 38, 557-574, 2012 | 181 | 2012 |
| Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform … S Bertagnolio, SS Thwin, R Silva, S Nagarajan, W Jassat, R Fowler, ... The Lancet HIV 9 (7), e486-e495, 2022 | 112 | 2022 |
| Symptom burden in chronic kidney disease; a population based cross sectional study S Senanayake, N Gunawardena, P Palihawadana, P Bandara, R Haniffa, ... BMC nephrology 18, 1-8, 2017 | 97 | 2017 |
| Performance of critical care prognostic scoring systems in low and middle-income countries: a systematic review R Haniffa, I Isaam, AP De Silva, AM Dondorp, NF De Keizer Critical care 22, 1-22, 2018 | 91 | 2018 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47, 867-886, 2021 | 86 | 2021 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 81 | 2023 |
| Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial CA Bradbury, PR Lawler, SJ Stanworth, BJ McVerry, Z McQuilten, ... Jama 327 (13), 1247, 2022 | 79 | 2022 |
| Quality metrics for the evaluation of Rapid Response Systems: Proceedings from the third international consensus conference on Rapid Response Systems CP Subbe, J Bannard-Smith, J Bunch, R Champunot, MA DeVita, ... Resuscitation 141, 1-12, 2019 | 72 | 2019 |
| Casemix, management, and mortality of patients receiving emergency neurosurgery for traumatic brain injury in the Global Neurotrauma Outcomes Study: a prospective observational … D Clark, A Joannides, AO Adeleye, AH Bajamal, T Bashford, H Biluts, ... The Lancet Neurology 21 (5), 438-449, 2022 | 63 | 2022 |
| Effectiveness of tocilizumab, sarilumab, and anakinra for critically ill patients with COVID-19 the REMAP-CAP COVID-19 immune modulation therapy domain randomized clinical trial REMAP-CAP Investigators, LPG Derde, AC Gordon, PR Mouncey, ... MedRxiv, 2021.06. 18.21259133, 2021 | 59 | 2021 |
| Simplified prognostic model for critically ill patients in resource limited settings in South Asia R Haniffa, M Mukaka, SB Munasinghe, AP De Silva, KSA Jayasinghe, ... Critical Care 21, 1-8, 2017 | 58 | 2017 |
